In the discovery phase (Cohort 1), RBD status was evaluated via validated questionnaires (RBDQ-HK, cutoff of 18 for the diagnosis of RBD, detailed in the Methods section, Supplementary Fig
Addressing these issues requires standardized functional criteria, improved peptidomics and ribosome profiling, structural and interactome studies, and longterm agingrelevant endpoints in preclinical models
GLP-1s can also be used for weight management because they slow down how quickly food leaves the stomach, which promotes feelings of fullness and reduces overall calorie intake, explains Darji, adding, They also affect areas of the brain to decrease hunger cues. All of this can help you feel full longer, which ultimately results in eating less
In clinical trials of GLP-1 medications, fat loss far outweighs losses of lean mass
Numerous clinical trials have demonstrated semaglutides safety and efficacy as a powerful weight loss therapy